SCHEMBL7467284

SCHEMBL7467284

CC(CN1CCN(c2ccc(Nc3ncc4c(n3)C(C3CCCC3)C(O)=CC4)cc2)CC1)C(N)C=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.39
RPS6KA6 Q9UK32 1/20 0.39
CDK4 P11802 7/20 0.38
AURKA O14965 2/20 0.38
CDK1 P06493 2/20 0.38
INSR P06213 1/20 0.38
PDGFRB P09619 1/20 0.38
SRC P12931 1/20 0.38
PDGFRA P16234 1/20 0.38
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
KDR P35968 1/20 0.38
CDK7 P50613 1/20 0.38
NTRK2 Q16620 1/20 0.38
CCND1 P24385 5/20 0.38
CCNE1 P24864 3/20 0.38
CDK2 P24941 3/20 0.38
CCNT1 O60563 2/20 0.38
CDK9 P50750 2/20 0.38
CDK6 Q00534 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7476134 0.90 CDK4 (0.40) EGFRRPS6KA6CDK4AURKACDK1
SCHEMBL7468092 0.90 EGFR (0.38) EGFRRPS6KA6CDK4CDK1CCND1
SCHEMBL7467084 0.88 JAK3 (0.38) EGFRRPS6KA6CDK4CDK1KDR
SCHEMBL7463354 0.85 ERBB3 (0.41) EGFRCDK4AURKACDK1INSR
SCHEMBL7469937 0.85 CDK4 (0.41) EGFRCDK4AURKACDK1INSR
SCHEMBL7462456 0.84 SYK (0.43) EGFRCDK4AURKACDK1INSR
SCHEMBL6087101 0.83 SYK (0.44) EGFRCDK4CDK1CCND1CCNE1
SCHEMBL6087785 0.81 SYK (0.43) EGFRCDK4CDK1CCND1CCNE1
SCHEMBL6087449 0.81 CDK4 (0.46) EGFRCDK4AURKACDK1INSR
SCHEMBL7464943 0.81 EGFR (0.39) EGFRRPS6KA6CDK4AURKACDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP disclosed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO disclosed